Morishita Jintan Co., Ltd. (4524.T)

JPY 2065.0

(0.05%)

EBITDA Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual EBITDA in 2023 was 1.29 Billion JPY , up 11.26% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly EBITDA in 2024 Q1 was 461 Million JPY , up 368.02% from previous quarter.
  • Morishita Jintan Co., Ltd. reported an annual EBITDA of 1.19 Billion JPY in 2022, up 34.19% from previous year.
  • Morishita Jintan Co., Ltd. reported an annual EBITDA of 885 Million JPY in 2021, up 9.51% from previous year.
  • Morishita Jintan Co., Ltd. reported a quarterly EBITDA of 348 Million JPY for 2023 Q3, up 34.36% from previous quarter.
  • Morishita Jintan Co., Ltd. reported a quarterly EBITDA of 259 Million JPY for 2023 Q2, down -33.07% from previous quarter.

Annual EBITDA Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Morishita Jintan Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 1.29 Billion JPY 11.26%
2022 1.19 Billion JPY 34.19%
2021 885 Million JPY 9.51%
2020 814 Million JPY -31.35%
2019 1.24 Billion JPY 0.0%

Peer EBITDA Comparison of Morishita Jintan Co., Ltd.

Name EBITDA EBITDA Difference
Pharma Foods International Co., Ltd. 6.02 Billion JPY 78.525%
Takeda Pharmaceutical Company Limited 874.6 Billion JPY 99.852%
Sumitomo Pharma Co., Ltd. -281.07 Billion JPY 100.46%
Shionogi & Co., Ltd. 186.7 Billion JPY 99.307%
Wakamoto Pharmaceutical Co.,Ltd. 570.97 Million JPY -126.456%
Nippon Shinyaku Co., Ltd. 36.29 Billion JPY 96.437%
Kaken Pharmaceutical Co., Ltd. 12.26 Billion JPY 89.46%
Eisai Co., Ltd. 103.1 Billion JPY 98.746%
Hisamitsu Pharmaceutical Co., Inc. 18.34 Billion JPY 92.95%
Mochida Pharmaceutical Co., Ltd. 8.97 Billion JPY 85.59%
Fuso Pharmaceutical Industries,Ltd. 3.67 Billion JPY 64.768%
Nippon Chemiphar Co., Ltd. 1.4 Billion JPY 7.84%
Tsumura & Co. 30.77 Billion JPY 95.798%
Kissei Pharmaceutical Co., Ltd. 18.72 Billion JPY 93.093%
Torii Pharmaceutical Co., Ltd. 5.27 Billion JPY 75.47%
Towa Pharmaceutical Co., Ltd. 35.53 Billion JPY 96.361%
Fuji Pharma Co., Ltd. 6.88 Billion JPY 81.212%
Zeria Pharmaceutical Co., Ltd. 17.52 Billion JPY 92.621%
KYORIN Holdings, Inc. 10.29 Billion JPY 87.442%
Taiko Pharmaceutical Co.,Ltd. -3.75 Billion JPY 134.48%
Daito Pharmaceutical Co.,Ltd. 7.55 Billion JPY 82.881%
SymBio Pharmaceuticals Limited -714 Million JPY 281.092%
MedRx Co., Ltd -884.51 Million JPY 246.182%
Mizuho Medy Co.,Ltd. 5.53 Billion JPY 76.645%
Solasia Pharma K.K. -635 Million JPY 303.622%
Modalis Therapeutics Corporation -2.37 Billion JPY 154.467%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.16 Billion JPY 85.889%
Sawai Group Holdings Co., Ltd. 36.87 Billion JPY 96.493%
Cyfuse Biomedical K.K. -538.28 Million JPY 340.206%
Toho Holdings Co., Ltd. 25.84 Billion JPY 94.997%
Koa Shoji Holdings Co.,Ltd. 5.1 Billion JPY 74.655%